ARROWHEAD PHARMACEUTICALS IN
ARWR · NASDAQ
Updated at 2026-10-14 12:34:30
- Today's High
- $60.73
- Today’s Low
- $58.08
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $62.49
- Previous Close
- $60.73
- Volume
- 1.19M
- Market Cap
- $8.57B
- P/E Ratio
- --
- EPS
- $-2.24
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 177 EAST COLORADO BOULEVARD, PASADENA, CA, UNITED STATES, 91105
- Country
- US
- Listing Date
- 1993-12-14
- Fiscal Year End
- September
- Shares Outstanding
- 140.86M
- CIK
- 0000879407
- Website
- arrowheadpharma.com
Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.
Financial Metrics
Revenue
2026-06-30
$75.25M
2026-03-31
$73.73M
2025-12-31
$264.03M
2025-09-30
$256.47M
Operating Expenses
2026-06-30
$245.34M
2026-03-31
$214.99M
2025-12-31
$223.22M
2025-09-30
$212.36M
Net Income
2026-06-30
-$194.28M
2026-03-31
-$132.73M
2025-12-31
$30.81M
2025-09-30
-$23.75M
Net Profit Margin
2026-06-30
-258.16%
2026-03-31
-180%
2025-12-31
11.66%
2025-09-30
-9.26%
Earnings Per Share
2026-06-30
$-1.36
2026-03-31
$-0.93
2025-12-31
$0.22
2025-09-30
$-0.11
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$147.68M
2026-03-31
-$107.35M
2025-12-31
$57.16M
2025-09-30
$64.2M
Effective Tax Rate
2026-06-30
0%
2026-03-31
0%
2025-12-31
0.1%
2025-09-30
55.36%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $75.25M | $73.73M | $264.03M | $256.47M |
| Operating Expenses | $245.34M | $214.99M | $223.22M | $212.36M |
| Net Income | -$194.28M | -$132.73M | $30.81M | -$23.75M |
| Net Profit Margin | -258.16% | -180% | 11.66% | -9.26% |
| Earnings Per Share | $-1.36 | $-0.93 | $0.22 | $-0.11 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$147.68M | -$107.35M | $57.16M | $64.2M |
| Effective Tax Rate | 0% | 0% | 0.1% | 55.36% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.